About Index Trending news
Analyze
Pricing
Cidara Therapeutics

Cidara Therapeutics

Cidara Therapeutics

Cidara is focused on developing novel anti-infectives to address serious infections.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Grant
$6,900,000
CARB-X
Post-IPO debt
$20,000,000
Employees

Team size

10+
Locations
HQ
$6,900,000 Grant
biospace , businesswire

Cidara Awarded 6 9 Million Grant From CARB X To Advance Development Of Its First Cloudbreak Antibiotic Immunotherapy

$20,000,000 Post-IPO debt
FinSMEs

Cidara Therapeutics Receives $20M Credit Facility from Square 1 Bank